Tower Research Capital LLC (TRC) - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 138 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q4 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.1%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q3 2023$42,106
-88.4%
1,648
-86.9%
0.00%
-91.7%
Q2 2023$361,855
+269941.0%
12,617
+125.7%
0.01%
+200.0%
Q1 2023$134
+737.5%
5,591
+496.7%
0.00%
+300.0%
Q4 2022$16
-100.0%
937
-74.9%
0.00%0.0%
Q3 2022$55,000
-50.9%
3,727
-47.7%
0.00%
-66.7%
Q2 2022$112,000
+1144.4%
7,130
+2028.4%
0.00%
Q1 2022$9,000
-89.5%
335
-85.6%
0.00%
-100.0%
Q4 2021$86,000
-62.4%
2,323
-51.5%
0.00%
-83.3%
Q3 2021$229,000
+387.2%
4,786
+241.9%
0.01%
+500.0%
Q2 2021$47,000
-89.0%
1,400
-86.5%
0.00%
-85.7%
Q1 2021$428,000
+17.9%
10,357
+23.8%
0.01%
-36.4%
Q4 2020$363,000
+108.6%
8,365
+105.9%
0.01%
+450.0%
Q3 2020$174,000
+411.8%
4,062
+458.7%
0.00%
+100.0%
Q2 2020$34,000
-12.8%
727
-79.6%
0.00%
-66.7%
Q4 2019$39,0003,569
+6763.5%
0.00%
Q2 2019$0520.00%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q4 2020
NameSharesValueWeighting ↓
Tri Locum Partners LP 208,886$5,337,0371.71%
Portolan Capital Management 276,505$7,064,7030.66%
Nikko Asset Management Americas, Inc. 1,388,574$35,422,5230.42%
Green Alpha Advisors, LLC 21,538$550,2960.42%
SummerHaven Investment Management, LLC 22,326$570,4290.42%
ARK Investment Management 1,901,546$48,584,5080.37%
Granahan Investment Management 398,862$10,190,9240.36%
FEDERATED HERMES, INC. 4,711,512$120,379,1320.32%
Woodline Partners LP 1,069,814$27,333,7480.32%
Diametric Capital, LP 26,130$667,6210.28%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders